首页 | 本学科首页   官方微博 | 高级检索  
     

冬虫夏草联合NP方案治疗晚期非小细胞肺癌的临床观察
引用本文:郝 琳,汪 荃,王 冰,王怀瑾. 冬虫夏草联合NP方案治疗晚期非小细胞肺癌的临床观察[J]. 大连医科大学学报, 2007, 29(6): 563-565
作者姓名:郝 琳  汪 荃  王 冰  王怀瑾
作者单位:大连黄海医院,肿瘤中心,辽宁,大连,116021;大连瓦房店市中心医院,肿瘤科,辽宁,大连,116300;大连大学,附属新华医院,肿瘤中心,辽宁,大连,116021
摘    要:[目的]观察冬虫夏草联合NP方案治疗晚期非小细胞肺癌的疗效和毒副反应.[方法]治疗组:NP方案化疗3~4个周期,同时服用冬虫夏草颗粒.冬虫夏草2包/d(225 mg/包),餐前或餐中用水服用.对照组:NP方案化疗方法同治疗组,不服用冬虫夏草颗粒.观察指标:治疗前后CT肿块大小、卡氏评分、T细胞亚群的变化;药物毒副反应情况.[结果]治疗组试验完成情况(化疗通过率):完成12例、中止5例,化疗通过率70.6%;对照组:完成11例、中止5例,化疗通过率68.7%.治疗组CR 2例,PR 4例,SD 4例.有效率35.3%,受益率58.8%.对照组CR 0例,PR 6例,SD 3例.有效率37.5%,受益率56.3%.治疗组2例CR,略好于对照组,但两组统计学处理差异无显著性意义.治疗组卡氏评分变化不大,但对照组有2例明显下降.而在毒副反应方面:对照组病人呕吐、发热、感染的发生率均高于治疗组.[结论]冬虫夏草对肿瘤化疗有一定的辅助作用.

关 键 词:冬虫夏草  长春瑞滨  顺铂  联合化疗  非小细胞肺癌
文章编号:1671-7295(2007)06-0563-03
收稿时间:2007-09-28
修稿时间:2007-11-09

Clinical observation of cordyceps combined with NP regimen in treatment of advanced non-small cell lung cancer
HAO Lin,WANG Quan,WANG Bing and WANG Huai-Jin. Clinical observation of cordyceps combined with NP regimen in treatment of advanced non-small cell lung cancer[J]. Journal of Dalian Medical University, 2007, 29(6): 563-565
Authors:HAO Lin  WANG Quan  WANG Bing  WANG Huai-Jin
Abstract:[Objective] To observe the efficacy and toxicity of patients of Cordyceps combined with NP regimen in treating patients with advanced non-small cell lung cancer.[Methods] The treated group: chemotherapy with NP regimen for 3~4 cycles.Cordyceps was given simultaneously.Take Cordyceps with water 2 kits a day(225 mg/kit) before or during the meal.The control group was given NP regimen the same with The treated group,but Cordyceps was not given.The observation indexes were the size of tumor compared before treatment with after treatment by CT,karnofsky score,the change of T cell subset and the toxicity.[Results] The completed condition of the treated group(chemotherapy passed rate):12 completed,6 intermittenced,chemotherapy passed rate 70.6%;the control group 11 completed,6 intermittenced,chemotherapy passed rate 68.7%.The treated group: CR 2,PR 4,SD 4,the response rate 35.3%,the disease control rate 58.8%.The control group CR 0 PR 6 SD 3,the response rate 37.5%,the disease control rate 56.3%(9/16),the treated group was a little better than the control group on CR 2,but there was no difference between the two groups.The change of karnofsky score was analogous in the treated group,but there was 2 patients whose karnofsky score was obervious loss.The occurrence rate such as vomit,fever,and infection in the control group was higher than that in the treated group.[Conclusion] Cordyceps is useful to the accessory function on the chemotherapy of tumor.
Keywords:cordyceps    vinorelbine    cisplatin   combined chemotherapy    non - small cell lung cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号